Cargando…

Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine

IMPORTANCE: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and oral HPV infection is associated with increased risk of oropharyngeal cancer. OBJECTIVE: To describe the risk factors for oral HPV in sexually active female adolescents receiving the qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlecht, Nicolas F., Masika, Martin, Diaz, Angela, Nucci-Sack, Anne, Salandy, Anthony, Pickering, Sarah, Strickler, Howard D., Shankar, Viswanathan, Burk, Robert D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822084/
https://www.ncbi.nlm.nih.gov/pubmed/31651968
http://dx.doi.org/10.1001/jamanetworkopen.2019.14031
_version_ 1783464268113379328
author Schlecht, Nicolas F.
Masika, Martin
Diaz, Angela
Nucci-Sack, Anne
Salandy, Anthony
Pickering, Sarah
Strickler, Howard D.
Shankar, Viswanathan
Burk, Robert D.
author_facet Schlecht, Nicolas F.
Masika, Martin
Diaz, Angela
Nucci-Sack, Anne
Salandy, Anthony
Pickering, Sarah
Strickler, Howard D.
Shankar, Viswanathan
Burk, Robert D.
author_sort Schlecht, Nicolas F.
collection PubMed
description IMPORTANCE: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and oral HPV infection is associated with increased risk of oropharyngeal cancer. OBJECTIVE: To describe the risk factors for oral HPV in sexually active female adolescents receiving the quadrivalent vaccine. DESIGN, SETTING, AND PARTICIPANTS: Longitudinal cohort study involving repeated collection of oral rinse specimens from sexually active female adolescents conducted between October 19, 2007, and March 9, 2017, at a large adolescent health center in New York, New York, that provides free health care, including HPV vaccination. EXPOSURES: Human papillomavirus vaccination and self-reported history of sexual behavior. MAIN OUTCOMES AND MEASURES: Prevalence of HPV in the oral cavity. RESULTS: Among the 1259 participants who were included in this study, median age at entry into the study was 18 (range, 13-21) years; 638 (50.7%) were of African American descent, 569 (45.2%) were of Hispanic descent, 43 (3.4%) reported another race/ethnicity, and race/ethnicity was unspecified for 9 (0.7%). The median (mode) age at first sexual activity was 14.8 (14) years, and 1161 (92.2%) reported having had oral sex. Human papillomavirus DNA was detected in baseline oral rinse samples of 78 of the 1259 participants (6.2%; 95% CI, 4.9%-7.6%). There was a significant decrease in oral HPV detection with time (in years) since first engaging in sexual activities, independent of age and concurrent detection of cervical HPV; comparing 4 or more years with 1 year or less, the odds ratio was 0.45 (95% CI, 0.21-0.96). Detection of vaccine types (HPV-6, HPV-11, HPV-16, and HPV-18) was significantly lower among participants who had received at least 1 dose of the quadrivalent HPV vaccine at the time of enrollment compared with those who were unvaccinated (odds ratio, 0.20; 95% CI, 0.04-0.998). CONCLUSIONS AND RELEVANCE: This study’s findings suggest that detection of HPV in the oral cavity is not uncommon in sexually active female adolescents. In addition, HPV vaccination is associated with a significant decrease in detection of HPV vaccine types in the oral cavity.
format Online
Article
Text
id pubmed-6822084
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-68220842019-11-14 Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine Schlecht, Nicolas F. Masika, Martin Diaz, Angela Nucci-Sack, Anne Salandy, Anthony Pickering, Sarah Strickler, Howard D. Shankar, Viswanathan Burk, Robert D. JAMA Netw Open Original Investigation IMPORTANCE: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and oral HPV infection is associated with increased risk of oropharyngeal cancer. OBJECTIVE: To describe the risk factors for oral HPV in sexually active female adolescents receiving the quadrivalent vaccine. DESIGN, SETTING, AND PARTICIPANTS: Longitudinal cohort study involving repeated collection of oral rinse specimens from sexually active female adolescents conducted between October 19, 2007, and March 9, 2017, at a large adolescent health center in New York, New York, that provides free health care, including HPV vaccination. EXPOSURES: Human papillomavirus vaccination and self-reported history of sexual behavior. MAIN OUTCOMES AND MEASURES: Prevalence of HPV in the oral cavity. RESULTS: Among the 1259 participants who were included in this study, median age at entry into the study was 18 (range, 13-21) years; 638 (50.7%) were of African American descent, 569 (45.2%) were of Hispanic descent, 43 (3.4%) reported another race/ethnicity, and race/ethnicity was unspecified for 9 (0.7%). The median (mode) age at first sexual activity was 14.8 (14) years, and 1161 (92.2%) reported having had oral sex. Human papillomavirus DNA was detected in baseline oral rinse samples of 78 of the 1259 participants (6.2%; 95% CI, 4.9%-7.6%). There was a significant decrease in oral HPV detection with time (in years) since first engaging in sexual activities, independent of age and concurrent detection of cervical HPV; comparing 4 or more years with 1 year or less, the odds ratio was 0.45 (95% CI, 0.21-0.96). Detection of vaccine types (HPV-6, HPV-11, HPV-16, and HPV-18) was significantly lower among participants who had received at least 1 dose of the quadrivalent HPV vaccine at the time of enrollment compared with those who were unvaccinated (odds ratio, 0.20; 95% CI, 0.04-0.998). CONCLUSIONS AND RELEVANCE: This study’s findings suggest that detection of HPV in the oral cavity is not uncommon in sexually active female adolescents. In addition, HPV vaccination is associated with a significant decrease in detection of HPV vaccine types in the oral cavity. American Medical Association 2019-10-25 /pmc/articles/PMC6822084/ /pubmed/31651968 http://dx.doi.org/10.1001/jamanetworkopen.2019.14031 Text en Copyright 2019 Schlecht NF et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Schlecht, Nicolas F.
Masika, Martin
Diaz, Angela
Nucci-Sack, Anne
Salandy, Anthony
Pickering, Sarah
Strickler, Howard D.
Shankar, Viswanathan
Burk, Robert D.
Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine
title Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine
title_full Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine
title_fullStr Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine
title_full_unstemmed Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine
title_short Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine
title_sort risk of oral human papillomavirus infection among sexually active female adolescents receiving the quadrivalent vaccine
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822084/
https://www.ncbi.nlm.nih.gov/pubmed/31651968
http://dx.doi.org/10.1001/jamanetworkopen.2019.14031
work_keys_str_mv AT schlechtnicolasf riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine
AT masikamartin riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine
AT diazangela riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine
AT nuccisackanne riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine
AT salandyanthony riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine
AT pickeringsarah riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine
AT stricklerhowardd riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine
AT shankarviswanathan riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine
AT burkrobertd riskoforalhumanpapillomavirusinfectionamongsexuallyactivefemaleadolescentsreceivingthequadrivalentvaccine